*3.1. Quantifying Changes in No-DTP Children from 2000 to 2019*

Among the 56 LMICs included in this analysis, 44 (78.6%) had some kind of reduction in both national levels of no-DTP and subnational gaps in no-DTP prevalence between 2000 and 2019 (Figure 1; Table 2). In contrast, five countries—Benin, Kenya, Guinea, Papua New Guinea, and Uzbekistan—had at least some increase in both estimated national and subnational gaps in no-DTP prevalence. Five countries decreased national no-DTP levels between 2000 and 2019, but in tandem saw subnational gaps increase to some degree: Congo (an 8.4 percentage-point rise); Tajikistan (2.1 percentage points); Djibouti (0.7 percentage points); Central African Republic (0.6 percentage points); and São Tomé and Príncipe (0.4 percentage points). Two countries—Haiti and Myanmar– had the national percentage of under-one children with no DTP doses at least somewhat increase since 2000 while subnational gaps declined; this was particularly pronounced for Myanmar (a 6.1 percentage-point rise).

**Table 2.** Comparing levels and changes in no-DTP prevalence, nationally and for subnational gaps, from 2000 to 2019 for 56 LMICs. Bolded countries are those with the largest progress in reducing zero-dose children for both national and subnational gaps, based on the difference between the 5th and 95th percentiles for no-DTP prevalence at the second-level administrative unit, for either absolute or relative declines from 2000 to 2019. pp = percentage-points.



**Table 2.** *Cont.*
